My Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Healthcare Reporter.

Press releases published on September 1, 2026

Sep. 1, 2026

Olympia Pharmaceuticals Adds Gonadorelin to Its Growing Men’s Hormone Portfolio

Indeterminate GlobeNewswire

Sep. 1, 2026

Patients Suffering from Primary Biliary Cholangitis (PBC) Push Back on Stigma

Indeterminate GlobeNewswire

Sep. 1, 2026

Easy Environmental Solutions Reports Fiscal 2026 Results and Continued Revenue Growth

Indeterminate GlobeNewswire

Sep. 1, 2026

BICEL™ SOFT TIP I/A terralution™. Diseñado para la delicadeza. Sostenible por naturaleza*.

Indeterminate GlobeNewswire

Sep. 1, 2026

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

Indeterminate GlobeNewswire

Sep. 1, 2026

SAB BIO to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Tris Pharma to Showcase ADHD Leadership and Commitment to Individualized Care at Fall 2026 Medical Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Conexeu Sciences Sets September and October 2026 Conference Schedule

Indeterminate GlobeNewswire

Sep. 1, 2026

Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026

Indeterminate GlobeNewswire

Sep. 1, 2026

CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

SCYNEXIS to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

DnaK Therapeutics & GATC Health Forge A Partnership To Evaluate, Accelerate & Prioritize Cancer Drug Candidates Using AI Platform

Indeterminate GlobeNewswire

Sep. 1, 2026

CytoDyn Closes $16.5 Million Financing to Fund Continued Development of Leronlimab

Indeterminate GlobeNewswire

Sep. 1, 2026

Celcuity To Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Polaryx Therapeutics Appoints Dr. Will Charlton as Chief Medical Officer

Indeterminate GlobeNewswire

Sep. 1, 2026

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

Sep. 1, 2026

Biomerica Reports Fiscal 2026 Year-End Financial Results

Indeterminate GlobeNewswire

Sep. 1, 2026

VivoSim Labs to Add Rat Liver Model to NAMkind Platform

Indeterminate GlobeNewswire

Sep. 1, 2026

San Francisco Bay Coffee Featured on NBC California Live

Indeterminate EIN Presswire